[1]
C. R., J., R. N., D. and B. L., S. 2017. Efficacy and safety of topical BAK-free travoprost 0.004% versus BAK-preserved travoprost 0.004% in the treatment of primary open angle glaucoma: a comparative study at a tertiary care hospital. International Journal of Basic & Clinical Pharmacology. 6, 9 (Aug. 2017), 2199–2205. DOI:https://doi.org/10.18203/2319-2003.ijbcp20173744.